William Blair acted as the exclusive advisor to Medalogix, a portfolio company of The Vistria Group, in connection with its acquisition and concurrent merger with Forcura by Berkshire Partners. The transaction signed on January 30, 2025, and closed on March 18, 2025. This transaction marks William Blair’s 7th signed or closed advisory deal in Healthcare Technology in 2025.
About the Companies
Medalogix is a pioneer in the post-acute care space, offering unique data analytics solutions to transform home health and hospice stakeholders through decision support and risk enablement tools for providers and risk-bearing entities (RBEs). Leveraging data science, machine learning and AI, and innovative cloud technology, Medalogix equips clinicians and agencies to provide the right care at the right time, resulting in improved patient outcomes as well as reduced costs for providers and reduced total cost of care.
Founded in 1984, Berkshire Partners is a private equity firm based in Boston, Massachusetts. The firm prefers to invest in companies operating in the consumer products, retailing and related services, business and financial services, technology, industrials, and healthcare sectors. Berkshire Partners is a leading private equity firm with a track record of success spanning over 30 years. The firm’s investment strategy is both disciplined and opportunistic.
The Vistria Group is building a new kind of private investment firm that seeks to deliver both financial returns and societal impact. It invests in essential industries like real estate, healthcare, knowledge and learning solutions, and financial services that deliver value for investors as well as communities, employees, and consumers. With more than $12.9 billion in AUM, The Vistria Group looks deeper by working as a true partner, drawing on its deep sector knowledge, operational expertise, unique network, diverse team, and impact orientation to achieve transformational growth.
Learn more about our healthcare IT investment banking expertise.